Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 2:3
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 3
1 (25.0%)Cognitive, Emotional, Physical and Psychosocial Effects of Panax Quinquefolius L
Phase 2
Completed
- Conditions
- MemoryLearningAttentionCognitionWell-Being
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 72
- Registration Number
- NCT00527969
- Locations
- 🇨🇦
PNL, Edmonton, Alberta, Canada
Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
Phase 2
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2007-07-17
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 50
- Registration Number
- NCT00435968
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
Phase 3
Completed
- Conditions
- Upper Respiratory Infection
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2009-06-08
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 500
- Registration Number
- NCT00259831
- Locations
- 🇨🇦
The Capital Care Group Continuing Care facilities, Edmonton, Alberta, Canada
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Phase 2
Completed
- Conditions
- Upper Respiratory Infection
- First Posted Date
- 2005-11-18
- Last Posted Date
- 2007-06-18
- Lead Sponsor
- CV Technologies
- Target Recruit Count
- 75
- Registration Number
- NCT00255307
- Locations
- 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada
🇨🇦Misericordia Child Health Clinic, Edmonton, Alberta, Canada
News
No news found